Two arthritis drugs slash the risk of Covid patients in ICU dying by 24%
Boris Johnson tonight hailed two new tongue-twisting arthritis drugs after a major British trial revealed they cut the risk of death in critically-ill Covid patients by nearly a quarter. The PM said the anti-inflammatory drugs tocilizumab and sarilumab — which he struggled to pronounce at tonight’s Downing Street press conference — would be made available through the NHS … Read more